Stock info MDxHealth | Filter  Basic-Info

Stock: MDxHealth (Bel small), ISIN: BE0003844611

Last Price 3.02 Max Price 3.09
Min Price 0.22 1 Year return 243.18
Avg. Target 0.90 Expected Return -70.20 %
Sector Health Care Subsector Biotechnology
Sell 0 Rating Star full 12x12Star full 12x12Star full 12x12Star full 12x12Star full 12x12
Hold 0 Concensus Cons buy
Buy 1
Annual report 2018

OncoMethylome Sciences is a molecular diagnostics company developing gene methylation tests for early cancer detection and personalized treatment decisions. OncoMethylome Sciences was founded in 2003 and is headquartered in Belgium. Its offices and laboratories are located in Belgium, the Netherlands and the USA (Durham, NC). OncoMethylome Sciences’ stocks are traded on the Euronext Amsterdam and the company is a component of the Local Securities-index (ISIN: BE0003844611/ Mnemo: ONCOA).

Loading...

Contact info:Zip Code: 4000 LiegeCity: LiegeCountry: BelgiumPhone: 32 (0) 4 364 20Email: ir@mdxhealth.comWebsite: www.mdxhealth.com

Sector Review MDxHealth

Loading...
Year Turnover Total sector Market share
2019 12 141,925 0.01 %
2020 18 170,231 0.01 %
2021 22 252,886 0.01 %
2022 37 238,500 0.02 %
2023 0 0 0.00 %

Advice MDxHealth

Date Label Bank Label Stock Label Advice Label Price Label Diff Label
October 10, 2023 KBC Securities MDxHealth Buy 0.90 -235.56 %
May 22, 2023 KBC Securities MDxHealth Buy 0.90 -235.56 %
August 05, 2022 KBC Securities MDxHealth Buy 1.50 78.00 %
November 11, 2021 KBC Securities MDxHealth Buy 1.20 39.17 %
March 03, 2021 KBC Securities MDxHealth Buy 1.25 44.80 %
March 02, 2021 Oppenheimer & Co MDxHealth Buy 2.00 62.00 %
October 21, 2020 KBC Securities MDxHealth Buy 1.00 -23.00 %
April 09, 2020 KBC Securities MDxHealth Hold 0.90 -27.78 %
February 26, 2020 DeGroof Petercam MDxHealth Hold 1.10 30.91 %
November 12, 2019 KBC Securities MDxHealth Hold 1.10 24.55 %
September 27, 2019 DeGroof Petercam MDxHealth Sell 1.10 30.91 %
August 29, 2019 KBC Securities MDxHealth Hold 1.30 44.62 %
January 17, 2019 Berenberg MDxHealth Hold 1.50 49.33 %
November 15, 2018 Berenberg MDxHealth Hold 1.85 46.49 %
October 23, 2018 KBC Securities MDxHealth Buy 3.50 70.91 %
September 10, 2018 Berenberg MDxHealth Buy 5.80 81.38 %
February 28, 2018 KBC Securities MDxHealth Buy 4.90 61.22 %
December 28, 2017 DeGroof Petercam MDxHealth Hold 4.10 60.49 %
November 06, 2017 KBC Securities MDxHealth Buy 5.50 67.42 %
November 02, 2017 DeGroof Petercam MDxHealth Buy 5.50 67.27 %
July 06, 2017 DeGroof Petercam MDxHealth Buy 6.00 36.67 %
November 05, 2016 DeGroof Petercam MDxHealth Buy 6.10 31.51 %
November 03, 2016 KBC Securities MDxHealth Buy 6.50 27.25 %
September 27, 2016 DeGroof Petercam MDxHealth Buy 5.30 9.43 %
September 22, 2016 KBC Securities MDxHealth Buy 6.00 20.10 %
November 03, 2015 DeGroof Petercam MDxHealth Buy 4.70 0.21 %
October 07, 2015 KBC Securities MDxHealth Buy 5.50 21.09 %
August 18, 2015 KBC Securities MDxHealth Buy 6.50 40.86 %
May 05, 2015 Petercam MDxHealth Buy 5.30 85.66 %
February 26, 2015 Petercam MDxHealth Buy 5.30 45.28 %
January 26, 2015 KBC Securities MDxHealth Buy 6.50 40.77 %
September 12, 2014 KBC Securities MDxHealth Buy 5.50 22.56 %
September 18, 2012 Beursexpres MDxHealth Hold
December 20, 2011 Beursexpres MDxHealth Hold
April 05, 2011 Beleggers Belangen MDxHealth Sell
December 28, 2010 Beursexpres MDxHealth Hold
June 22, 2010 Beleggers Belangen MDxHealth Sell
June 21, 2010 Beursexpres MDxHealth Hold
March 15, 2010 ING MDxHealth Hold 3.50
January 29, 2010 Beursexpres MDxHealth Hold



News MDxHealth

Past years share MDxHealth huge underperformer

The past years MDxHealth had a huge negative momentum. The stock made the past 5 years a huge loss of 38 percent. With that the stock belongs to the worst shares of the biotech companies. The sector yielded the past 5 years a gain of at around 243 percent. Other...

Annual reports MDxHealth

2017 2018 2019 2020 2021

Profile MDxHealth

MDxHealth

(BE0003844611)/ MDXH

The past year was a good year for MDxHealth investors

The stock gained over the past 12 months at around 26 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 215 percent. MDxHealth's revenues between 2011 and 2015 were far from constant and moved between 4,48 million euros and 16,24 million euros. MDxHealth's net results between 2011 and 2015 were far from constant and moved between -7,46 million euros and 0 million euros.

The headquarter of MDxHealth is located in Liege. MDxHealth primarily operates in the biotech sector. The global biotech companies gained around 59 percent over the period 2006-2016. Measured since 2011 the sector is 70 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 59 percent.

The Belgian company didn't pay out any dividends (in the past 5 years).

At the end of 2015 around 84 people were employed at MDxHealth.

MDxHealth financed with relatively low debt

As per the end of 2015 the Belgian company's balance sheet equaled 0 million euros. The total debt of the biotech company was at the end of 2015 0 million euros, which equals around percent of the total balance sheet.

At the end of 2015 the biotech company's market size (her number of outstanding share times the stock price) equaled around 183,32 million euros. At the end of 2015 around 45,15 million stocks were listed.

All the company's financial reports are available here. More information about MDxHealth can be found it's website. .


Results MDxHealth

Results
2015
2016
2017
2018
2019
2020
Revenue
18
30
41
28
12
18
Costs
32
43
53
61
55
47
Profit
-14
-13
-12
-32
-43
-29
Margin of profit
-82.03
-43.94
-30.34
-114.26
-365.56
-155.25
ROI
-32.69
-24.97
-28.22
-62.26
-218.56
-489.91

Balance MDxHealth

Balance
2015
2016
2017
2018
2019
2020
Equity
44
53
44
52
20
6
Debt
13
15
15
13
21
26
Total assets
58
68
59
65
41
32
Solvency
76.65
77.88
74.42
79.60
48.54
18.36
Cash
32
31
17
26
22
16
Cashflow
-14
-17
-10
-29
-22
-20
Employees
95
162
232
187
0
Revenue per employee
0.19
0.18
0.17
0.15
0.0
Cashflow / Debt
-1.07
-1.11
-0.70
-2.14
-1.07
-0.78

Details MDxHealth

Details
2016
2017
2018
2019
2020
Price
4.12
4.79
3.21
1.85
1.04
Eps
-0.29
-0.25
-0.56
-0.69
-0.34
Price/earnings-ratio
-14.21
-19.16
-5.73
-2.68
-8.88
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
1.06
0.87
0.87
0.28
0.06
Market to book
0.26
0.18
0.27
0.15
0.02
Cashflow per stock
-0.33
-0.21
-0.48
-0.32
-0.22
Stocks
50
50
60
71
91
Market Cap
205.36
239.26
192.41
130.48
273.89

Dividend MDxHealth


Price info MDxHealth

Date
Price
22 Mar 2024
3.02
18 Mar 2024
3.02
15 Mar 2024
3.02
12 Mar 2024
3.02
11 Mar 2024
3.02
09 Mar 2024
3.02
07 Mar 2024
3.02
01 Mar 2024
3.02
29 Feb 2024
3.02
27 Feb 2024
3.02
22 Feb 2024
3.02
21 Feb 2024
3.02
20 Feb 2024
3.02
15 Feb 2024
3.02
14 Feb 2024
3.02
13 Feb 2024
3.02
09 Feb 2024
3.02
08 Feb 2024
3.02
07 Feb 2024
3.02
06 Feb 2024
3.02
05 Feb 2024
3.02
01 Feb 2024
3.02
31 Jan 2024
3.02
30 Jan 2024
3.02
27 Jan 2024
3.02
25 Jan 2024
3.02
24 Jan 2024
3.02
23 Jan 2024
3.02
16 Jan 2024
3.02
11 Jan 2024
3.02